0001140361-14-013089.txt : 20140317 0001140361-14-013089.hdr.sgml : 20140317 20140317172343 ACCESSION NUMBER: 0001140361-14-013089 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140313 FILED AS OF DATE: 20140317 DATE AS OF CHANGE: 20140317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hartman Thomas E CENTRAL INDEX KEY: 0001466989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 14698525 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc1.xml FORM 4 X0306 4 2014-03-13 0 0000722723 HANGER, INC. HGR 0001466989 Hartman Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 VP and General Counsel Common Stock 2014-03-13 4 S 0 330 34.0515 D 11621 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $34.00 to $34.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Consists of (i) unvested restricted shares totaling 1,731 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014; (ii) unvested restricted shares and fully vested shares totaling 2,916 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; (iii) unvested restricted shares and fully vested shares totaling 3,049 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012; (iv) unvested restricted shares totaling 2,300 shares from an initial grant of 4,600 shares of restricted stock made on March 25, 2011 and [continued in next footnote] (v) unvested restricted shares totaling 1,625 from an initial grant of 6,500 shares of restricted stock made on March 30, 2010 and cumulatively vest to the extent of one-quarter each year thereafter, subject to certain provisions under the Plan, and which shall become fully vested upon a termination of employment not involving termination for cause or voluntary termination. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman 2014-03-17